IE870122L - Treatment of coronary disease - Google Patents

Treatment of coronary disease

Info

Publication number
IE870122L
IE870122L IE870122A IE12287A IE870122L IE 870122 L IE870122 L IE 870122L IE 870122 A IE870122 A IE 870122A IE 12287 A IE12287 A IE 12287A IE 870122 L IE870122 L IE 870122L
Authority
IE
Ireland
Prior art keywords
treatment
coronary disease
coronary
compound
formula
Prior art date
Application number
IE870122A
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IE870122L publication Critical patent/IE870122L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A compound of the formula I <IMAGE> or its acid addition salts is used for the treatment of coronary disorders or organic brain syndrome. [DE3601562A1]
IE870122A 1986-01-21 1987-01-20 Treatment of coronary disease IE870122L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863601562 DE3601562A1 (en) 1986-01-21 1986-01-21 USE OF AMINO ACID DERIVATIVES FOR THE TREATMENT OF CORONARY DISEASES AND ORGANIC BRAIN SYNDROME

Publications (1)

Publication Number Publication Date
IE870122L true IE870122L (en) 1987-07-21

Family

ID=6292232

Family Applications (1)

Application Number Title Priority Date Filing Date
IE870122A IE870122L (en) 1986-01-21 1987-01-20 Treatment of coronary disease

Country Status (4)

Country Link
JP (1) JPS62215523A (en)
DE (1) DE3601562A1 (en)
IE (1) IE870122L (en)
ZA (1) ZA87378B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU742853B2 (en) * 1997-07-31 2002-01-17 Ube Industries, Ltd. N-acylamino acid amide compounds and intermediates for preparation thereof

Also Published As

Publication number Publication date
JPS62215523A (en) 1987-09-22
ZA87378B (en) 1988-09-28
DE3601562A1 (en) 1987-08-27

Similar Documents

Publication Publication Date Title
AU1331588A (en) Method for treatment of alcohol abuse
AU7194991A (en) Macrolide pharmaceutical solutions
HUT45984A (en) Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts
AU649882B2 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
ES2001341A6 (en) Novel guanidinomethylbenzoic acid derivatives.
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
EP0302967A3 (en) Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
FI864970A0 (en) NYA KRISTALLINA SALTER AV ARYLOXI-PROPANOLAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING.
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
SE8601799D0 (en) (-) - 1BETA-ETHYL-1ALFA-HYDROXYMETHYL-1,2,3,4,6,7,12,12BALFA-OCTAHYDROINDOLO / 2,3-A / QUINOLIZINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
EP0471388A3 (en) Medicament for the treatment of cardiac insufficiency
FI913951A7 (en) Process for the preparation of crystalline 7-amino-3-(5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthiomethyl)-ceph-3-hemi-4-carboxylic acid (TACS)
AU557772B2 (en) I-furyl-3,4-dihydroisoquinolines
AU1099688A (en) Substituted 3-phenyl-7h-thiazolo(2,2-b)(1,2,4)triazin-7-ones, a process for the preparation thereof, medicaments containing same and the use thereof, and also some intermediates formed in the preparation of the compounds mentioned
SE8705068D0 (en) Crystalline salts AV / 3S (Z) / - 2 - /// 1- (2-AMINO-4-THIAZOLYL) -2 - // 2,2-DIMETHYL-4-OXO-1- (SULPHOOXY) -3-AZETIDINYL / -AMINO / -2oxoethylidene / -AMINO / OXI / ETTIKSYRA
FR2604707B1 (en) PROCESS FOR THE PREPARATION OF AN ACTIVE THERAPEUTIC COMPOUND
AR243159A1 (en) Procedure for the preparation of 1-(3-mercaptan-(2s)-methylpropionyl)-pyrolidine-(2s)-carb&lt;543&gt;oxylic acid or its pharmaceutically acceptable salts.
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
FI881032A7 (en) Process for the preparation of N-acetyl-3-fluoroneuraminic acid derivatives.
NO903585D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-OCSAZINES.
ES533147A0 (en) A PROCEDURE FOR THE PREPARATION OF A COMPOUND
EP0392015A4 (en) Novel derivatives of physiologically active substance ml-236b and process for their preparation
EP0266426A4 (en) Pseudouridine derivative.
ATE109454T1 (en) CATECHOLAMINE ESTERS.